Zai Lab Limited

NASDAQ:ZLAB

Biotechnology

Healthcare
$21.92 +3.42%

+$0.61 today

Market cap
$2.47B
Beta
0.78
P/E (TTM)
-11.4
EPS (TTM)
-$0.16
52W Low $15.96High $41.20

Volume 0.61M

Average 0.87M

Returns on capital

Zai Lab Limited management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-24.5%

avg -16.9%

ROIC

-22.7%

avg -50.2%

ROA

-15.0%

avg -42.0%

Analysis

ROA is currently the strongest return metric at -15.0% versus its period average of -42.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Ying Du

Founder, Chairperson & Chief Executive OfficerUSD 1.62M6033.15K0.03%

Rafael G. Amado

President and Head of Global Research & DevelopmentUSD 957.59K62——

Frazor Titus Edmondson

Chief Legal Officer & Corporate SecretaryUSD 842.36K60——

Yajing Chen

Chief Financial OfficerUSD 743.42K580<0.01%

Shaun Maccoun

Executive Director of Global Communications————

Xiaoyu Chen

Executive Director of Regional Communications————

James Yan DABT

Chief Operating Officer of Global R&D—62——

Shan He

Senior Vice President & Chief Business Officer————

Christine Chiou

Senior Vice President & Head of Investor Relations————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 1, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$99,193.33

Sells

39

$11.11M

Net Transaction Value

−$11.01M

Net selling

Most Active

Du Ying

15 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

GAYNOR RICHARD

Direct

Buy$33.4K
Aug 19, 26

Chen Yajing

Direct

Sell$7K
Aug 12, 26

Lis William

Direct

Sell$212.7K
Aug 11, 26

Chen Yajing

Direct

Sell$15.5K
Jul 1, 26

GAYNOR RICHARD

Direct

Buy$33.1K
Jun 30, 26

Du Ying

Direct

Sell$130.2K
Jun 26, 26

Edmondson Frazor Titus III

Direct

Sell$71.6K
Jun 26, 26

Du Ying

Direct

Sell$428.5K
Jun 26, 26

Chen Yajing

Direct

Sell$39.5K
Jun 22, 26

Lis William

Direct

Sell$127.4K

1–10 of 42

Summary

Insiders reported 3 buys worth $99,193.33 and 39 sells worth $11.11M over the last 12 months. That adds up to net selling of $11.01M. Du Ying was the most active insider with 15 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/A+28.9%
+26.1% (5yr)6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Recent growth has been strongest in Revenue at +28.9% over three years. Forward estimates point to Revenue at +26.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Zai Lab Limited compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ZLAB's management, answered from reported figures.

Who manages ZLAB?

Zai Lab Limited (ZLAB) lists 9 active executives. The top listed executive is Shaun Maccoun, Executive Director of Global Communications.

Are ZLAB insiders buying or selling?

Recent insider activity shows net selling of $16.29M.